For research use only. Not for therapeutic Use.
Fluoxetine (Cat.No:I004030) is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed as an antidepressant. It works by increasing the levels of serotonin in the brain, helping to alleviate symptoms of depression, anxiety, and other mood disorders. Fluoxetine is also used in the treatment of bulimia nervosa, obsessive-compulsive disorder, and panic disorder.
| Catalog Number | I004030 |
| CAS Number | 54910-89-3 |
| Molecular Formula | C17H18F3NO |
| Purity | ≥95% |
| Target | SSRIs |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20°C |
| IUPAC Name | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
| InChI | InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3 |
| InChIKey | RTHCYVBBDHJXIQ-UHFFFAOYSA-N |
| SMILES | CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F |
| Reference | <p style=/line-height:25px/> <br>[2]. Fuller, R.W., K.W. Perry, and B.B. Molloy, Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine (Lilly 110140). Life Sci, 1974. 15(6): p. 1161-71. <br>[3]. Narita, N., et al., Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain. Eur J Pharmacol, 1996. 307(1): p. 117-9. <br>[4]. Hashimoto, K., Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. Cent Nerv Syst Agents Med Chem, 2009. 9(3): p. 197-204. </p> |
